Trial intelligence / Profile preview

Comparative study of prophylactic efficacy between conventional and new anticonvulsants in Thai cerebrovascular disease patients

TCTR20180111004Phase 1Active, not recruiting

Start
Jan 2017
Countries
1
01

Overview

Phase 1 trial in cerebrovascular disease and seizure (2 arms), sponsored by none. Primary endpoint: Prophylactic efficacy of anticonvulsants. Started Jan 2017; status: active, not recruiting.

02

Conditions

cerebrovascular diseaseseizure

Beyond the preview

Go deeper on TCTR20180111004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20180111004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call